| Followers | 241 |
| Posts | 15553 |
| Boards Moderated | 1 |
| Alias Born | 03/29/2014 |
Saturday, April 18, 2026 3:19:53 PM
Regarding your post:
You called the 10-K “Late” - it wasn’t, according to the forms that were filed for the 10k. What was late was the correction to the 1.01 form that was filed back in October 2025 to a 2.01. The 1.01 covers the entering into a material agreement while a 2.01 needs to be filed upon the closing of a significant acquisition. A error was made back in October and a 1.01 was filed instead of a 2.01. And so that error was corrected on April 7, 2026, but too late for even a “VP Pass” filer. So the S-3 eligibility was NOT lost due to any “forensic data” omitted as you suggest but simply for the error cited above.
https://wow.lw.com/Article/Index/104
2. You were correct, though, about the S-3 demotion, but not for the reasons you suggest.
As for items 3 - 5 - It’s all fascinating and I’m definitely paying attention (if only for the fun of it), but I do want to note the real reason for the S3 to S1 eligibility as what I've listed above.
You called the 10-K “Late” - it wasn’t, according to the forms that were filed for the 10k. What was late was the correction to the 1.01 form that was filed back in October 2025 to a 2.01. The 1.01 covers the entering into a material agreement while a 2.01 needs to be filed upon the closing of a significant acquisition. A error was made back in October and a 1.01 was filed instead of a 2.01. And so that error was corrected on April 7, 2026, but too late for even a “VP Pass” filer. So the S-3 eligibility was NOT lost due to any “forensic data” omitted as you suggest but simply for the error cited above.
https://wow.lw.com/Article/Index/104
2. You were correct, though, about the S-3 demotion, but not for the reasons you suggest.
As for items 3 - 5 - It’s all fascinating and I’m definitely paying attention (if only for the fun of it), but I do want to note the real reason for the S3 to S1 eligibility as what I've listed above.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
